Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    • News

  • Stakk Secures T-Mobile Contract to Power Super App Expansion
    Stakk Secures T-Mobile Contract to Power Super App Expansion
    • News

  • Medibank Backs Emyria with Landmark Depression Care Deal
    Medibank Backs Emyria with Landmark Depression Care Deal
    • News

  • NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    • News

  • BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    • News

  • Harris Technology eyes profitability as refurbished tech sales surge
    Harris Technology eyes profitability as refurbished tech sales surge
    • News

  • QIC Fund Backs Ark Mines with $4.5m to Accelerate Sandy Mitchell Development
    • News

  • Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    • News

  • FBR’s tech could help reduce housing construction-related cost pressures
    FBR’s tech could help reduce housing construction-related cost pressures
    • News

  • Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    • News

Global Health’s refreshed healthcare data management system bags them a valuable contract

  • In News
  • August 1, 2022
  • Samantha Freidin
Global Health’s refreshed healthcare data management system bags them a valuable contract

Take it from someone who used to work in the space, health care data management systems leave a lot to be desired. 

Most are old, clunky and cumbersome, and still come at a premium. 

Global Health (ASX: GLH) is looking to change that with their suite of healthcare software applications, all designed to connect clinicians and consumers. 

The digital health software solutions pay special attention to patient engagement and connectivity across multiple specialities in the healthcare sector. 

So far, their software has assisted over 3 million patients achieve optimal health outcomes and is used by over 10,000 healthcare providers across various locations across the country.

Adding to that list, Global Health has signed a new contract with Latrobe Community Health to provide a range of their applications, advancing their service for patients and optimising workflows for clinicians.

Operating over 50 sites comprising over 1000 employees, the health service is the biggest community health agency in Gippsland, Victoria. Latrobe Community Health offers a range of services including home care packages, aged care support, chronic disease management and general health services. 

To further improve the health of the community they operate in, the not-for-profit is investing in their digital infrastructure, implementing Global Health solutions: MasterCare EMR, Data warehouse, MasterCare Connect, e-switch integration and Referral Net SMD. 

The MasterCare solution is a fully integrated health practice platform and will assist with the delivery and scaling of services as it is capable of managing the large and complex data needs of the organisation. 

The platform looks after every aspect of healthcare visits including referrals, triage, billing, invoicing, Medicare claiming and clinical note taking. 

Valued at approximately $360,000 in annual recurring revenue, the contract is a significant win for Global Health, and has 2 options for 2 year extensions baked in too. 

The new deal sets a strong benchmark for the Company moving into FY23, establishing MasterCare as a competitive player in the SaaS healthcare software market. 

“We are delighted that Latrobe Community Health, a highly respected, progressive and large community health provider has chosen MasterCare as an integrated solution for their health care needs,” said Michael Davies, CEO of Global Health. “Latrobe Community Health operates across Gippsland and also in metro Melbourne offering a wide range of services. We are excited to offer a solution that not only works for today but can develop as the community health service expands more services across Victoria in the coming years. 

“This solution will help Latrobe Community Health improve patient outcomes through increased accessibility, enable better decision making at the point of care with mobile solutions and improve coordination across all their services.” 

Latrobe Community Health joins a host of other similar services that have signed on to use Global Health’s tools, including Monash Health, Bellarine Community Health and Peninsula Health.  

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  •  
  •  
  •  
  •  
  • advent health
  • data
  • GLH
  • Global Health
  • health
  • healthcare
  • software
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.